FDA Approves Lipfendra: Breakthrough Pill to Lower Bad Cholesterol
The U.S. Food and Drug Administration on Thursday granted approval for Merck’s Lipfendra, a new oral medication indicated for the treatment of patients with primary hyperlipidemia. The regulatory decision marks ... Read More